AQST Aquestive Therapeutics Inc

USD 4.50 0.58 14.795918
Icon

Aquestive Therapeutics Inc (AQST) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 4.50

+0.58 (+14.80)%

USD 0.35B

5.78M

USD 8.44(+87.65%)

N/A

Icon

AQST

Aquestive Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 4.50
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.35B

N/A

USD 4.50

Aquestive Therapeutics Inc (AQST) Stock Forecast

USD 8.44
(+87.65%)

Based on the Aquestive Therapeutics Inc stock forecast from 6 analysts, the average analyst target price for Aquestive Therapeutics Inc is USD 8.44 over the next 12 months. Aquestive Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Aquestive Therapeutics Inc is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, Aquestive Therapeutics Inc’s stock price was USD 4.50. Aquestive Therapeutics Inc’s stock price has changed by +10.02% over the past week, -18.33% over the past month and +246.15% over the last year.

No recent analyst target price found for Aquestive Therapeutics Inc
No recent average analyst rating found for Aquestive Therapeutics Inc

Company Overview Aquestive Therapeutics Inc

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenor...Read More

https://www.aquestive.com

30 Technology Drive, Warren, NJ, United States, 07059

135

December

USD

USA

Adjusted Closing Price for Aquestive Therapeutics Inc (AQST)

Loading...

Unadjusted Closing Price for Aquestive Therapeutics Inc (AQST)

Loading...

Share Trading Volume for Aquestive Therapeutics Inc Shares

Loading...

Compare Performance of Aquestive Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AQST

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Aquestive Therapeutics Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VTRS
Viatris Inc +0.02 (+0.18%) USD14.11B 237.70 8.88

ETFs Containing AQST

Symbol Name AQST's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Aquestive Therapeutics Inc (AQST) Stock

Based on ratings from 6 analysts Aquestive Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 9 buy, sell and hold ratings.

Unfortunately we do not have enough data on AQST's stock to indicate if its a good dividend stock.

Based on targets from 6 analysts, the average taret price for AQST is USD 8.44 over the next 12 months. The maximum analyst target price is USD 10 while the minimum anlayst target price is USD 7.

Unfortunately we do not have enough data on AQST's stock to indicate if its overvalued.

The last closing price of AQST's stock was USD 4.50.

The most recent market capitalization for AQST is USD 0.35B.

Based on targets from 6 analysts, the average taret price for AQST is projected at USD 8.44 over the next 12 months. This means that AQST's stock price may go up by +87.65% over the next 12 months.

We can't find any ETFs which contains Aquestive Therapeutics Inc's stock.

As per our most recent records Aquestive Therapeutics Inc has 135 Employees.

Aquestive Therapeutics Inc's registered address is 30 Technology Drive, Warren, NJ, United States, 07059. You can get more information about it from Aquestive Therapeutics Inc's website at https://www.aquestive.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...